ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
This study has been withdrawn prior to enrollment.
First Posted: April 17, 2007
Last Update Posted: August 24, 2016
Information provided by (Responsible Party):